Before we can address the macro issues of lowering costs, we must address our culture of over-testing
Early goal-directed therapy raises the age-old question about end-of-life treatment in the ED. How much is too much?
Direct-to-consumer drug advertising might seem egregious, but the onus is on you, the EP, to make the call. 
The truth is, “Marketplace medicine” may not work. Are we asking the tough questions about health care economics? 
Will in-store clinics help with ED overcrowding or become a drain on reimbursement? 

Popular Authors

  • Greg Henry
  • Rick Bukata
  • Mark Plaster
  • Kevin Klauer
  • Jesse Pines
  • David Newman
  • Rich Levitan
  • Ghazala Sharieff
  • Nicholas Genes
  • Jeannette Wolfe
  • William Sullivan
  • Michael Silverman

Earn CME Credit